Blood and lymphatic cancer : targets and therapy

Keyphrases

Publications

volume 14, 2024

Dan Liu, Juan Tong, Erling Chen, Li Wang, Lei Xue, Xuhan Zhang, Na Zhao, Xing Hu, Chang-Cheng Zheng
Highly Curative Treatment of High-Risk Acute Promyelocytic Leukemia: Induction and Consolidation with ATRA+ATO+anthracyclines and Maintenance with ATRA+RIF. Blood and lymphatic cancer : targets and therapy 14 (2024)
Jie Zhang, Yuhuan Zheng, Hongjuan Liu, Bo Liu
AC024896.1/miR-363-3p Axis Regulates the Malignant Progression of Acute Myeloid Leukemia by Cuproptosis-Related Gene MYO1B. Blood and lymphatic cancer : targets and therapy 14 (2024)
Francesco Malfona, Anna Maria Testi, Sabina Chiaretti, Maria Luisa Moleti
Refractory Burkitt Lymphoma: Diagnosis and Interventional Strategies. Blood and lymphatic cancer : targets and therapy 14 (2024)
Jie Zhang, Yuhuan Zheng, Hongjuan Liu, Bo Liu
AC024896.1/miR-363-3p Axis Regulates the Malignant Progression of Acute Myeloid Leukemia by Cuproptosis-Related Gene MYO1B. Blood and lymphatic cancer : targets and therapy 14 (2024)
Francesco Malfona, Anna Maria Testi, Sabina Chiaretti, Maria Luisa Moleti
Refractory Burkitt Lymphoma: Diagnosis and Interventional Strategies. Blood and lymphatic cancer : targets and therapy 14 (2024)
Yingzi Zhang, Xiajuan Yao, Yaoquan Zhang, Zhuyun Chen, Zhongke Qin, Ying Cai, Wenkai Xia, Hong Hu
Albumin-to-Globulin Ratio Combined with Neutrophil-to-Lymphocyte Ratio as a Prognostic Predictor in Multiple Myeloma with Renal Impairment. Blood and lymphatic cancer : targets and therapy 14 (2024)
Nan Mei, Sha Gong, Lizhao Wang, Lu Wang, Jincheng Wang, Jianpeng Li, Yingying Bao, Huanming Zhang, Huaiyu Wang
Identification of a Prognostic Model Based on NK Cell-Related Genes in Multiple Myeloma Using Single-Cell and Transcriptomic Data Analysis. Blood and lymphatic cancer : targets and therapy 14 (2024)
Dan Liu, Juan Tong, Erling Chen, Li Wang, Lei Xue, Xuhan Zhang, Na Zhao, Xing Hu, Chang-Cheng Zheng
Highly Curative Treatment of High-Risk Acute Promyelocytic Leukemia: Induction and Consolidation with ATRA+ATO+anthracyclines and Maintenance with ATRA+RIF. Blood and lymphatic cancer : targets and therapy 14 (2024)
Nan Mei, Sha Gong, Lizhao Wang, Lu Wang, Jincheng Wang, Jianpeng Li, Yingying Bao, Huanming Zhang, Huaiyu Wang
Identification of a Prognostic Model Based on NK Cell-Related Genes in Multiple Myeloma Using Single-Cell and Transcriptomic Data Analysis. Blood and lymphatic cancer : targets and therapy 14 (2024)
Yingzi Zhang, Xiajuan Yao, Yaoquan Zhang, Zhuyun Chen, Zhongke Qin, Ying Cai, Wenkai Xia, Hong Hu
Albumin-to-Globulin Ratio Combined with Neutrophil-to-Lymphocyte Ratio as a Prognostic Predictor in Multiple Myeloma with Renal Impairment. Blood and lymphatic cancer : targets and therapy 14 (2024)

volume 13, 2023

Naji Bou Zeid, Victor Yazbeck
PI3k Inhibitors in NHL and CLL: An Unfulfilled Promise. Blood and lymphatic cancer : targets and therapy 13 (2023)
Andrea Duminuco, Patrick Harrington, Claire Harrison, Natalia Curto-Garcia
Polycythemia Vera: Barriers to and Strategies for Optimal Management. Blood and lymphatic cancer : targets and therapy 13 (2023)
Nada Alsuhebany, Congshan Pan, Eileen Holovac, Brian Do, Ali McBride
Zanubrutinib in Mantle Cell Lymphoma Management: A Comprehensive Review. Blood and lymphatic cancer : targets and therapy 13 (2023)
Naji Bou Zeid, Victor Yazbeck
PI3k Inhibitors in NHL and CLL: An Unfulfilled Promise. Blood and lymphatic cancer : targets and therapy 13 (2023)
Tesfaye Gessese, Fikir Asrie, Zewudu Mulatie
Human Immunodeficiency Virus Related Non-Hodgkin's Lymphoma. Blood and lymphatic cancer : targets and therapy 13 (2023)
ErinMarie O Kimbrough, Vivek Gupta, Liuyan Jiang, Han W Tun
Successful Anatomy Adapted Therapeutic Management and Genetic Profiling of Primary Pituitary Diffuse Large B-Cell Lymphoma. Blood and lymphatic cancer : targets and therapy 13 (2023)
Andrea Duminuco, Patrick Harrington, Claire Harrison, Natalia Curto-Garcia
Polycythemia Vera: Barriers to and Strategies for Optimal Management. Blood and lymphatic cancer : targets and therapy 13 (2023)
Jing Wang, Firas Baidoun, Han W Tun, Muhamad Alhaj Moustafa
90 Yttrium Ibritumomab Tiuxetan (Zevalin) for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Report of 5 Cases. Blood and lymphatic cancer : targets and therapy 13 (2023)
Munawwar Hussain, Sarvari Yellapragada, Samer Al Hadidi
Differential Diagnosis and Therapeutic Advances in Multiple Myeloma: A Review Article. Blood and lymphatic cancer : targets and therapy 13 (2023)

volume 12, 2022

Shashank Cingam, Surbhi Sidana
Differential Diagnosis of Waldenström's Macroglobulinemia and Early Management: Perspectives from Clinical Practice. Blood and lymphatic cancer : targets and therapy 12 (2022)
Kyaw Hein, Nicholas Short, Elias Jabbour, Musa Yilmaz
Clinical Value of Measurable Residual Disease in Acute Lymphoblastic Leukemia. Blood and lymphatic cancer : targets and therapy 12 (2022)
Adam M Kase, Catherine Bullock, Ricardo Parrondo, Muhamad Alhaj Moustafa, Madiha Iqbal, K David Li, Ephraim E Parent, Han W Tun
Neuropsychiatric Manifestations of Lymphoma-Associated Cerebral Glucose Hypometabolism Can Be Reversed by Intensive Glucose Supplementation. Blood and lymphatic cancer : targets and therapy 12 (2022)
Jing Wang, Muhamad Alhaj Moustafa, Justin J Kuhlman, Karan Seegobin, Liuyan Jiang, Vivek Gupta, Han W Tun
Intravascular Large B Cell Lymphoma with CNS Involvement Successfully Treated with High-Dose Methotrexate and High-Dose Ara-C Based CNS-Directed Chemoimmunotherapy Alternating with Anthracycline Based Chemoimmunotherapy. Blood and lymphatic cancer : targets and therapy 12 (2022)
Justin J Kuhlman, Muhamad Alhaj Moustafa, Liuyan Jiang, Jing Wang, Vivek Gupta, Han W Tun
Long-Term Survival with Ibrutinib Therapy in Elderly Patients with Newly Diagnosed Primary Central Nervous System Lymphoma. Blood and lymphatic cancer : targets and therapy 12 (2022)
Ayenew Berhan, Biruk Bayleyegn, Zegeye Getaneh
HIV/AIDS Associated Lymphoma: Review. Blood and lymphatic cancer : targets and therapy 12 (2022)
Krishna R Juluri, Chloe Siu, Ryan D Cassaday
Asparaginase in the Treatment of Acute Lymphoblastic Leukemia in Adults: Current Evidence and Place in Therapy. Blood and lymphatic cancer : targets and therapy 12 (2022)
Clement Chung
A Promising Future for Precision Epigenetic Therapy for Follicular and Diffuse Large B-Cell Lymphoma? Blood and lymphatic cancer : targets and therapy 12 (2022)
Matthew J Rendo, Jacinth J Joseph, Liem Minh Phan, Christin B DeStefano
CAR T-Cell Therapy for Patients with Multiple Myeloma: Current Evidence and Challenges. Blood and lymphatic cancer : targets and therapy 12 (2022)
Amanda Blackmon, Ibrahim Aldoss, Brian J Ball
FLT3 Inhibitors as Maintenance Therapy after Allogeneic Stem-Cell Transplantation. Blood and lymphatic cancer : targets and therapy 12 (2022)
Frédérique St-Pierre, Shuo Ma
Use of BTK Inhibitors in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): A Practical Guidance. Blood and lymphatic cancer : targets and therapy 12 (2022)
Guru Subramanian Guru Murthy
How I Manage Patients with Chronic Myeloid Leukemia (CML): Perspectives from Clinical Practice. Blood and lymphatic cancer : targets and therapy 12 (2022)

volume 11, 2021

Georgios Pongas, Bruce D Cheson
Recent Advances in the Management of Patients with Relapsed/Refractory Follicular Lymphoma. Blood and lymphatic cancer : targets and therapy 11 (2021)
Vilas A Gupta, James Ackley, Jonathan L Kaufman, Lawrence H Boise
BCL2 Family Inhibitors in the Biology and Treatment of Multiple Myeloma. Blood and lymphatic cancer : targets and therapy 11 (2021)
Qiuju Liu, Brittny Major, Jennifer Le-Rademacher, Aref A Al-Kali, Hassan Alkhateeb, Kebede H Begna, Michelle A Elliott, Naseema Gangat, William J Hogan, C Christopher Hook, Scott H Kaufmann, Animesh Pardanani, Mrinal S Patnaik, Ayalew Tefferi, Alexandra P Wolanskyj-Spinner, Mark R Litzow, Mark R Litzow
The Impact of Obesity on the Outcomes of Adult Patients with Acute Lymphoblastic Leukemia - A Single Center Retrospective Study. Blood and lymphatic cancer : targets and therapy 11 (2021)
Karan Seegobin, Muhamad Alhaj Moustafa, Liuyan Jiang, Han W Tun
Successful Non-Transplant Treatment of Double Hit Richter Transformation with Long-Term Remission. Blood and lymphatic cancer : targets and therapy 11 (2021)
Galia Stemer, Jacob M Rowe, Yishai Ofran
Efficacy and Safety Profile of Ivosidenib in the Management of Patients with Acute Myeloid Leukemia (AML): An Update on the Emerging Evidence. Blood and lymphatic cancer : targets and therapy 11 (2021)
Cynthia Bender, Luke Maese, Maria Carter-Febres, Anupam Verma
Clinical Utility of Pegaspargase in Children, Adolescents and Young Adult Patients with Acute Lymphoblastic Leukemia: A Review. Blood and lymphatic cancer : targets and therapy 11 (2021)

volume 10, 2020

Audrey M Sigmund, Kieran D Sahasrabudhe, Bhavana Bhatnagar
Evaluating Blinatumomab for the Treatment of Relapsed/Refractory ALL: Design, Development, and Place in Therapy. Blood and lymphatic cancer : targets and therapy 10 (2020)
Chaitra Ujjani, Anthony Mato, Brian T Hill, John N Allan, Frederick Lansigan, Ryan Jacobs, Alan Skarbnik, Hande Tuncer, John Pagel, Danielle Brander, Bruce D Cheson, Paul Barr, Lindsey E Roeker, Jeffrey J Pu, Nirav N Shah, Andre H Goy, Stephen J Schuster, Nicole Lamanna, Alison Sehgal, Constantine S Tam, Mazyar Shadman
The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy. Blood and lymphatic cancer : targets and therapy 10 (2020)

volume 9, 2019

Juan Eduardo Megías-Vericat, Octavio Ballesta-López, Eva Barragán, Pau Montesinos
IDH1-mutated relapsed or refractory AML: current challenges and future prospects. Blood and lymphatic cancer : targets and therapy 9 (2019)
Fangwen Zhang, Ling Li, Lei Zhang, Xin Li, Xiaorui Fu, Xinhua Wang, Jingjing Wu, Zhenchang Sun, Fei Kong, Liangliang Ren, Mingzhi Zhang
Prognostic analysis of CD5 expression in double-hit diffuse large B-cell lymphoma and effectiveness comparison in patients treated with dose-adjusted EPOCH plus rituximab/R-CHOP regimens. Blood and lymphatic cancer : targets and therapy 9 (2019)
Giacomo Andreani, Daniela Cilloni
Strategies for minimal residual disease detection: current perspectives. Blood and lymphatic cancer : targets and therapy 9 (2019)
Catherine E Lai, Adrese Michael Kandahari, Chaitra Ujjani
The Evolving Role of Brentuximab Vedotin in Classical Hodgkin Lymphoma. Blood and lymphatic cancer : targets and therapy 9 (2019)
Manizheh Narimani, Mohammad Jafar Sharifi, Ali Jalili
Knockout Of BIRC5 Gene By CRISPR/Cas9 Induces Apoptosis And Inhibits Cell Proliferation In Leukemic Cell Lines, HL60 And KG1. Blood and lymphatic cancer : targets and therapy 9 (2019)
Michael Schieber, Shuo Ma
The expanding role of venetoclax in chronic lymphocytic leukemia and small lymphocytic lymphoma. Blood and lymphatic cancer : targets and therapy 9 (2019)
Giovanna Carrà, Antonio Cartellà, Beatrice Maffeo, Alessandro Morotti
Strategies For Targeting Chronic Myeloid Leukaemia Stem Cells. Blood and lymphatic cancer : targets and therapy 9 (2019)

volume 8, 2018

Carminia Lapuz, Anoop K Enjeti, Peter C O'Brien, Anne L Capp, Elizabeth G Holliday, Sanjiv A Gupta
Outcomes and relapse patterns following chemotherapy in advanced Hodgkin lymphoma in the positron emission tomography era. Blood and lymphatic cancer : targets and therapy 8 (2018)
Agnieszka Blum, Despina Bazou, Peter O'Gorman
Smoldering multiple myeloma: prevalence and current evidence guiding treatment decisions. Blood and lymphatic cancer : targets and therapy 8 (2018)
Alessandro Davide Videtta, Valeria Malagnino, Giulia De Falco
Current understanding of the role and regulation of miRNAs in Burkitt lymphoma. Blood and lymphatic cancer : targets and therapy 8 (2018)
Mehrdad Hefazi, Mark R Litzow
Recent advances in the biology and treatment of B-cell acute lymphoblastic leukemia. Blood and lymphatic cancer : targets and therapy 8 (2018)